Clinical Trial Update: A Randomized, Placebo-Controlled Clinical Trial of Intravitreal Triamcinolone for Refractory Diabetic Macular Edema [Phase 2]

View source ↗

Summary

Phase 2 randomized, placebo-controlled trial evaluating intravitreal Triamcinolone for refractory diabetic macular edema.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Macular Edema

Drugs mentioned

• Triamcinolone (triamcinolone)

Snippet

Sponsor: Shahid Beheshti University of Medical Sciences | Conditions: Diabetic Macular Edema | Phase 2 | Status: COMPLETED